Allergan Aesthetics Showcases Multimodal Treatment Approach at AMWC Dubai

What's Happening?

Allergan Aesthetics, a subsidiary of AbbVie, is set to present its AA Signature™ multimodal treatment approach at the Aesthetic Anti-Aging Medicine World Congress (AMWC) in Dubai. This approach, which has been launched in 25 countries this year, aims to meet evolving patient needs and enhance clinical practice. The AA Signature™ treatment utilizes Allergan's product portfolio and is supported by advanced education and business resources for healthcare professionals. The approach addresses globally recognized patient needs such as Lift Up, Distinct Definition, and improved skin quality. The AMWC event will feature a symposium hosted by the Allergan Medical Institute, where experts will explore the paradigm shift in medical aesthetics and decode the new AA Signature™ approach.

Why It's Important?

The presentation of the AA Signature™ treatment approach at AMWC Dubai highlights Allergan Aesthetics' commitment to advancing skin quality and meeting patient needs. This approach aligns with global aesthetic trends that favor a natural, individualized look. By leveraging its advanced portfolio, Allergan empowers healthcare professionals to deliver tailored multimodal treatment plans, strengthening patient relationships and encouraging long-term retention. The event also underscores the importance of integrating aesthetic modalities for holistic skin quality improvement, which is crucial as 94% of surveyed individuals express a desire to improve their facial skin quality.

What's Next?

Allergan Aesthetics plans to continue showcasing real-world results and data in the coming months, following the successful launch of the AA Signature™ approach in multiple countries. The company will host a series of 'Meet the Experts' sessions at the AMWC event, providing attendees with opportunities to explore the AA Signature approach and Allergan's facial aesthetics portfolio. Additionally, new clinical data and personalized aesthetics approaches will be presented through e-posters, furthering Allergan's commitment to innovation in the field.